| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |